IRRAS AB

79 articles about IRRAS AB

• IRRAS Publishes Annual Report for 2019

  3/20/2020

  IRRAS's annual report 2019 has been published on the company's website.

• IRRAS AB Publishes Interim Report for the Period January to December 2019

  2/14/2020

  The fourth quarter of 2019 was an important period of progress for IRRAS.

• IRRAS: Q4 Report 2019 - Invitation to Conference Call and Audiocast

  1/30/2020

  IRRAS will host a conference call and an online presentation of its Q4 2019 interim report.

• IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020

  1/7/2020

  IRRAS, a global healthcare company with a comprehensive portfolio of innovative solutions for neurocritical care, provides an update on the launch of its products in the United States and product portfolio objectives for 2020.

• IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care

  12/16/2019

  IRRAS announced the launch of its Hummingbird® ICP Monitoring product family in the United States.

• IRRAflow® Wins CONNECT's "2019 Most Innovative New Product" Award

  12/9/2019

  Breakthrough medical device that transforms treatment of intracranial bleeding recognized as most innovative new medical device from southern California

• IRRAS AB publishes Interim Report for the Period January to September 2019

  11/14/2019

  Since the US is the world's largest market for neurosurgical procedures, we have focused much of our team's resources toward supporting a successful early market introduction.

• IRRAS Announces Addition of Dr. Coenraad Tamse as Vice President, International Sales

  11/11/2019

  IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced the hiring of Dr. Coenraad Tamse as Vice President, International Sales.

• IRRAS - Q3 Report 2019 - Invitation to Conference Call and Audiocast

  10/31/2019

  On Thursday November 14, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q3 2019 interim report The presentation will be held in English..

• IRRAS Announces Participation at the 69th Congress of Neurological Surgeons' Annual Meeting (CNS 2019)

  10/18/2019

  IRRAS announced that it will be participating at the 69th Congress of Neurological Surgeons' Annual Meeting CNS 2019 is being held at the Moscone Center, West Building, in San Francisco, CA on October 19-23, 2019.

• IRRAS to Present at the 17th Neurocritical Care Society's Annual Meeting

  10/15/2019

  Company is co-hosting a Breakfast Symposium with the Neurocritical Care Society

• Q2 Report 2019 - Invitation to Conference Call and Audiocast

  8/29/2019

  CET IRRAS will host a conference call and an online presentation of its Q2 2019 interim report.

• IRRAS Publishes Interim Report for the Period January to June 2019

  8/29/2019

  During the second quarter, we reached a significant milestone by recording our first IRRAflow revenue in the United States.

• IRRAS Announces Issuance of New Patent for Core IRRAflow® Technology

  8/1/2019

  IRRAS AB, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced the issuance of United States Patent No. 10,293,105 for its "Fluid Exchange Catheter System" technology upon which the company's lead IRRAflow technology is based.

• IRRAS Wins Regulatory Approval of IRRAflow® in Israel and Costa Rica

  6/25/2019

  IRRAS AB announced that it received regulatory approval for its flagship product, IRRAflow, from the Ministries of Health in Israel and Costa Rica.

• IRRAS Announces Changes in Management Group

  6/18/2019

  IRRAS AB announced that Fredrik Alpsten, Chief Financial Officer, will leave IRRAS to pursue another opportunity outside of the company.

• IRRAS AB (PUBL) Interim Report January-March 2019

  5/7/2019

  Focus on US - first sales in US reported early April and acquisition of complementary products in May

• IRRAS Strengthens Position in Neurocritical Care by Acquiring Proprietary Assets, Including Four US FDA-cleared Products

  5/7/2019

  Assets complement IRRAflow® and support positioning as a leading company in the space

• IRRAS AB - Q1 Report 2019 - Invitation to Conference Call and Webcast

  5/7/2019

  Tuesday May 7, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q1 2019 interim report.

• IRRAS Establishes Collaborative Relationship With AMI-USC Through Acquisition of Complementary Medical Device Technology

  4/23/2019

  Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (AMI-USC) is a World Class Biomedical Engineering Technology Development Organization